The incidence of GnT-V positive expression in bladder cancer is significantly higher in lower grade/less invasive cancer than in higher grade/higher invasive cancer, which indicates that immunohistochemical detection of GnT-V can be used as a reliable marker for predicting the recurrence of superficial bladder cancer. This evidence concerns the gene MGAT5 and urinary bladder cancer.